Masong, Juvelyn -.

HRN: 20-53-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/09/2024
11/16/2024
IV
2.25g
Every 8hours
Pneumonia
Waiting Final Action 
11/09/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/11/2024
11/15/2024
IV
0.75g
Every After Hemodialysis
Pneumonia
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: